# Symptoms and phases in brain tumors
Brain tumors do not always progress in clearly defined phases like some other cancers. The course depends heavily on the type of tumor (glioma, meningioma, pituitary adenoma, or other type), its location in the brain, and how quickly the tumor grows. This page describes the most common symptoms and how the disease usually progresses, without making statements about your personal situation.
Early phase: before diagnosis or small, slow-growing tumor
In the beginning, a brain tumor often causes no complaints, especially if it is small or grows slowly. Symptoms develop only when the tumor:
- exerts pressure on surrounding brain tissue,
- causes swelling in the skull,
- disrupts blood vessels or nerves.
**Most common symptoms in this stage:**
- **Headache**: usually progressive (getting worse), sometimes worse in the morning, can wake from sleep
- **Vomiting or nausea**: often without clear reason, sometimes without prior abdominal pain
- **Balance problems**: dizziness, staggering, falling without clear cause
- **Vision problems**: blurred vision, double vision, visual field loss
- **Fatigue**: persistent tiredness that does not improve with rest
- **Concentration problems**: difficulty focusing, forgetfulness
- **Personality changes**: irritable mood, unusual behavior
- **Speech difficulties**: unclear speech, difficulty finding words
These complaints can persist for months before diagnosis. Many people seek help because these symptoms occur more frequently or do not go away with ordinary treatment (for example, painkillers for headaches do not help).
**Meaning for daily life:**
Routine tasks become more difficult. Driving becomes unsafe, concentration work becomes tiring, household tasks take more energy. Many people notice that they feel different than normal, without knowing why.
**Figures for this stage:**
Because symptoms can remain inconspicuous for a long time, a significant portion of brain tumors are discovered incidentally (for example, through imaging for other reasons). For slow-growing tumors such as low-grade gliomas, this phase can last for years; for aggressive tumors (high-grade glioma) usually only weeks to a few months. Precise duration figures are difficult because many tumors in this phase are not yet diagnosed.
---
Phase of diagnosis and further growth
At the time the tumor is discovered, symptoms may still be mild, or severe enough to require hospitalization. The tumor can be seen on MRI or CT, and pathological examination determines what type of tumor it is.
**Symptoms that now develop further or worsen:**
- **Neurological deficits**: weakness on one side of the body, tingling, loss of sensation
- **Seizures**: unexpected, without clear trigger; can be severe
- **Speech or language problems**: difficulty speaking, understanding or reading words
- **Memory and concentration disorders**: increasingly clear, affects work and home
- **Visual disorders**: visual field loss on one side, disrupted image processing
- **Coordination disorders**: clumsiness, difficulty writing or fine motor skills
- **Blockages in fluid circulation**: can lead to hydrocephalus, with severe headache, vomiting, drowsiness
- **Hormonal problems**: if tumor is near pituitary (excessive thirst, changed menstruation, erectile problems, accelerated growth in children)
**Meaning for daily life:**
This phase is when someone usually can no longer drive on their own, when hospitalization and possible surgery take place, and when help at home is needed. Work is usually interrupted, social activities are limited.
**Figures and course:**
This depends a lot on the type of tumor. For high-grade gliomas (WHO grade III-IV, especially glioblastoma multiforme), the median survival without treatment is a few weeks to months; with standard treatment (surgery, radiation, chemotherapy), an average of 12—15 months (NCCN guidelines 2024). For low-grade gliomas (grade I-II), median survival can be many years — sometimes 5 to 10+ years. Meningiomas often have a slower course; many are benign and can remain stable for years after surgery. These numbers are population averages and say nothing about one person; individual attrition varies widely based on age, overall health, genetic characteristics of the tumor, and extent of surgical resection.
---
Phase after initial treatment (surgery and/or radiation/chemo)
After treatment, symptoms may decrease, but not always disappear completely. In this phase, a lot of attention is given to rehabilitation and surveillance (regular scans and checks).
**Possible symptoms and effects: **
- **Healing neurological failure**: may be slow, sometimes incomplete; rehabilitation helps
- **Fatigue**: very common after radiation and chemotherapy, can last for months
- **Cognitive problems** (chemo-brain, radiation-induced cognitive decline): difficulty concentrating, memory, slower thinking
- **Symptoms of treatment**: bald head after radiation, nausea from chemo (usually transient)
- **Mood changes**: depression, anxiety, tumour irritability, treatment and uncertainty
- **Seizures **: may continue to occur even after treatment
- **Second cancers**: very low risk, but radiation to the brain increases this slightly
**Meaning for daily life:**
Many people are gradually returning to normal activities, but not always completely. Work can be resumed in a modified form. Fatigue can continue to limit work, hobbies, and social life. Regular check-ups (MRI every 2—3 months, less frequent later) provide certainty, but can also cause anxiety.
**Figures for this stage:**
The disease-free period (time without tumor recurrence) varies greatly. For glioblastoma, this is an average of 6—9 months, after which many tumors recur (determined from major clinical studies, e.g. EORTC and RTOG studies from 2009—2015). For low-grade gliomas, patients can live years or decades without progression. For meningiomas that are completely removed, recurrence is sometimes very rare. Regular imaging helps detect recurrence early.
---
Phase of return (recurrence) or progression
Not all tumours recur, but many aggressive tumours do. Symptoms may be similar to the first presentation, or new.
**Symptoms of return: **
- **Old symptoms that come back**: headache, tiredness, difficulty concentrating
- **New neurological phenomena**: new weakness, speech problems, or other localization symptoms
- **Changed medication response**: epileptic medication works less well, painkillers no longer help
- **Cognitive deterioration**: faster progress, dementia-like features in some
**Meaning for daily life:**
Independence may continue to decline. Patients have a stronger need for professional care, guidance, and support. Second round treatment (resurgery, new radiation, other medication) is being considered, but impact is increasing.
**Figures for this stage:**
For glioblastoma, average survival after first recurrence is 6—8 months without treatment; with second treatment, often slightly longer (median overall survival average 1—2 years after diagnosis, studies 2020—2024). For slow-growing tumors, there can be years between first diagnosis and recurrence. The frequency of return and speed vary greatly from person to person.
---
Advanced phase with reduced treatment options
As tumours recur more aggressively or no longer respond to standard treatment, choices become more difficult. Some patients may try experimental medications (via trials); others opt for symptomatic care.
**Symptoms in this phase: **
- **Progressive neurological decline**: progressive weakness, immobility, speech difficulties
- **Cognitive clarity**: confusion, memory loss, personality changes
- **Hydrocephalus symptoms**: headache, vomiting, drowsiness may worsen
- **Seizures/attacks**: may become frequent and difficult to control
- **Pain**: may increase, sometimes from tumor, sometimes from treatment
- **Deeper fatigue**: mobility decreases, patient becomes more bedridden
**Meaning for daily life:**
Full-time professional care usually becomes necessary. Self-care is no longer possible. Many patients move to hospice or a specialized ward. Focus shifts from cure to comfort and quality of life.
**Numbers:**
Median survival in this phase is difficult to establish, because patient selection and management are highly variable. For glioblastoma, median overall survival (from diagnosis) is approximately 12–15 months with standard treatment; approximately 10% of patients reach 5-year survival (Stupp et al., Lancet Oncology 2009–2015 and NCCN Guidelines 2024). For other tumor types and grades these figures differ greatly. Individual survival depends on many factors: age, ECOG performance status, IDH status (for gliomas), genetic markers, and extent of initial tumor.
---
Alarm: when to contact your doctor
Patients and their loved ones should contact their doctor (or go to the emergency room) if:
- **Suddenly much worse headache** than usual, especially with vomiting
- **New or much worse confusion, unconsciousness**
- **Sudden neurological deterioration**: new weakness, loss of speech, vision, widespread seizures
- **High fever without clear cause**
- **Persistent uncontrollable pain or vomiting** despite medication
- **Signs of infection** after surgery (redness, warmth, pus around wound)
These symptoms may indicate that intervention is urgently needed.
---
_This information never replaces a doctor's judgment. Always discuss your situation with your own healthcare provider._